Last reviewed · How we verify
NCT07345598
Central Venous Catheter Care Training for Pediatric Oncology Nurses
NA trial testing CVC Care Training in Pediatric Cancer in 30 participants. Not yet recruiting.
22 May 2026
Quick facts
| Lead sponsor | Fenerbahce University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 22 January 2026 |
| Primary completion | 22 May 2026 |
| Estimated completion | 22 June 2026 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- CVC Care Training
Conditions studied
- Pediatric Cancer — all drugs for Pediatric Cancer →
- Pediatric Oncology — all drugs for Pediatric Oncology →
- Central Venous Catheter — all drugs for Central Venous Catheter →
- Central Venous Catheter Placement — all drugs for Central Venous Catheter Placement →
Sponsor
Fenerbahce University
Who can join
Eligibility, any sex, with Pediatric Cancer or Pediatric Oncology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The knowledge level of nurses regarding care techniques plays a crucial role in the prevention of central venous catheter-related infections. This study was designed to evaluate the effect of training on central venous catheter care (CVCC), provided to nurses caring for pediatric oncology patients, on their knowledge level and infection prevention behaviors. The study aims to determine the effectiveness of an educational program intended to enhance nurses' knowledge and practical skills in preventing CVC-related infections, thereby contributing to evidence-based practices that improve patient safety.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07345598
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pediatric Cancer
Currently open trials in the same condition.
- NCT07506239 — Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma · NA · recruiting
- NCT07278778 — Cancer Care Companion · NA · recruiting
- NCT07473518 — Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy · recruiting
- NCT06939322 — LOG-I - Impact Study of LOG-AFTER Software on Long-term Monitoring of Former Patients (LOG-I - LOG-Impact Study) · NA · recruiting
- NCT07188311 — Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma · NA · recruiting
Other Fenerbahce University trials
Trials by the same sponsor.
- NCT07501871 — Digital Media Use and Treatment Adherence in Chemotherapy Patients · not yet recruiting
- NCT07490665 — Impact of Artificial Intelligence Discussion on Midwifery Students · NA · not yet recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07456956 — HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke · NA · recruiting
- NCT07447804 — Diaphragm Morphology and Respiratory Muscle Strength in Subacute Hemiplegic Patients · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07345598 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fenerbahce University
- Last refreshed: 15 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07345598.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing